Orient Europharma Co's quarterly market cap
declined
from Sep. 2023 (NT$3,704 Mil) to Dec. 2023 (NT$3,374 Mil) but then
increased
from Dec. 2023 (NT$3,374 Mil) to Mar. 2024 (NT$3,769 Mil).
Orient Europharma Co's annual market cap
declined
from Dec. 2021 (NT$3,153 Mil) to Dec. 2022 (NT$3,140 Mil) but then
increased
from Dec. 2022 (NT$3,140 Mil) to Dec. 2023 (NT$3,374 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Orient Europharma Co's Enterprise Value for Today is NT$6,710 Mil.
Orient Europharma Co Market Cap Historical Data
The historical data trend for Orient Europharma Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Orient Europharma Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Orient Europharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orient Europharma Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orient Europharma Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Orient Europharma Co's Market Cap falls into.
Orient Europharma Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Orient Europharma Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orient Europharma Co (ROCO:4120) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Orient Europharma Co Market Cap Related Terms
Thank you for viewing the detailed overview of Orient Europharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Orient Europharma Co (ROCO:4120) Business Description
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of f Western Pharmaceutical and Medical Devices. The firm also Manufacture Drugs and Medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:4120 has been successfully added to your 